Searchable abstracts of presentations at key conferences in endocrinology

ea0063p1062 | Pituitary and Neuroendocrinology 3 | ECE2019

Osteitis fibrosa cystica of the skull in a patient with primary hyperparathyroidism

Biban Georgiana Bianca , Baleanu Maria , Baculescu Nicoleta , Smarandache Romeo Marian , Corneci Cristina , Hortopan Dan , Poiana Catalina

Background: Overt parathyroid bone disease is a rare entity. We present a case of primary hyperparathyroidism (PHPT) and osteitis fibrosa cystica with involvement of multiple facial bones and neurocranium. Although the initial differential diagnosis was between acromegaly and bone malignancy, endocrine assessment demonstrated PHPT, with favorable outcome after parathyroidectomy.Case report: A 59-year-old woman referred to our clinic with painful swelling...

ea0070ep270 | Endocrine-related Cancer | ECE2020

All with men 2A in one family?

Lazar Diana-Georgiana , Vasilescu Sorana L. , Elena Oros Sabina , Dumitrascu Anda , Smarandache Romeo , Caragheorgheopol Andra

Multiple endocrine neoplasya type 2 (MEN-2) is a rare hereditary complex disorder caused by a germline activating mutation of the RET proto-oncogene. The estimated prevalence is approximately 1:30.000. Three clinical forms have been described depending on the phenotype: MEN2A (80%), MEN2B and familial medullary thyroid carcinoma (MTC).Clinically, MEN2A present with MTC (80–100%), unilateral or bilateral pheocromocytoma (40%) and primary hyperparath...

ea0081ep985 | Thyroid | ECE2022

An unusual association between medullary thyroid carcinoma and testicular seminoma: Chemotherapy-induced complications, genetic predisposition or random relationship?

Septar AIlin , Smarandache Romeo , Niculescu Dan Alexandru , Goldstein Andrei , Braha Elena , Muresan Andrei , Caragheorgheopol Andra , Terzea Dana , Constantin Teodor , Buduluca Larisa , Musat Madalina

Medullary thyroid carcinoma (MTC) is a rare malignancy arising from parafollicular C cells of the thyroid gland, sometimes due to germline mutations in the RET protooncogene. Testicular cancer is the most common malignancy in men aged 15 - 40 years with survival rates improved by the introduction of cisplatin therapy in the late 1970s. Nonetheless, platinum-based chemotherapy was shown to increase the risk of a solid second cancer with substantially increased site-specific ris...